Lantibiotics: biosynthesis, mode of action and applications.
about
Comparative genomics study of multi-drug-resistance mechanisms in the antibiotic-resistant Streptococcus suis R61 strainBioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogensTwo different lantibiotic-like peptides originate from the ericin gene cluster of Bacillus subtilis A1/3.Mechanistic studies on the substrate-tolerant lanthipeptide synthetase ProcMMutational analysis of the sbo-alb locus of Bacillus subtilis: identification of genes required for subtilosin production and immunity.Comparative genomics analysis of Streptococcus isolates from the human small intestine reveals their adaptation to a highly dynamic ecosystemProteomics of protein secretion by Bacillus subtilis: separating the "secrets" of the secretome.Catalytic promiscuity of a bacterial α-N-methyltransferase.Synthesis of pdCpAs and transfer RNAs activated with thiothreonine and derivatives.Spermicidal activity of the safe natural antimicrobial peptide subtilosinInhibition of Bacillus anthracis spore outgrowth by nisinSpecific interactions of clausin, a new lantibiotic, with lipid precursors of the bacterial cell wall.The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.Antimicrobial peptides: versatile biological properties.Strategies for the use of bacteriocins in Gram-negative bacteria: relevance in food microbiologyNew Found Hope for Antibiotic Discovery: Lipid II Inhibitors.Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.Purification and characterization of brochocin A and brochocin B(10-43), a functional fragment generated by heterologous expression in Carnobacterium piscicola.Synthesis of nisin AB dicarba analogs using ring-closing metathesis: influence of sp(3) versus sp(2) hybridization of the α-carbon atom of residues dehydrobutyrine-2 and dehydroalanine-5 on the lipid II binding affinity.Influence of shifting positions of Ser, Thr, and Cys residues in prenisin on the efficiency of modification reactions and on the antimicrobial activities of the modified prepeptides.NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides.Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770.Chemical and enzymatic synthesis of fluorinated-dehydroalanine-containing peptides.Synthesis and structural characterization of the individual diastereoisomers of a cross-stapled alkene-bridged nisin DE-ring mimic.Scalable purification of the lantibiotic nisin and isolation of chemical/enzymatic cleavage fragments suitable for semi-synthesis.Bacteriocins as food preservatives: Challenges and emerging horizons.Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal SystemDiscovery of Peptide Drugs from Natural Sources
P2860
Q28477218-E4DCC702-A7F9-421F-BDFE-D1886B575137Q28484253-F3DA4E6B-144F-4130-9B0C-3D691598A0E5Q30821398-67151196-38DA-4D11-B371-72D7155B5AFFQ33951197-69E5C784-7694-4265-9775-F06FA3D4CD66Q33994182-0486BC1F-5DA3-4DF5-AF65-3C7A4AE7EA57Q35080353-68BA35CF-D45D-49C9-B23B-6410F2F925F1Q35798768-8D54D93D-099D-4733-8ED0-8A790CFA5481Q36291975-B9FC1ABF-46FE-465F-A5A9-B34399404003Q36617647-FCFB33C4-E16D-4A86-AE50-F5E7BAEDB30BQ36932228-F81AABD9-F56E-4CE6-84BD-3DA353FEBB8FQ36993506-2D5B8D19-B495-41BB-B6F3-47EDDD478C81Q37359451-5666E710-A0BE-4247-AED3-9B4BB7921369Q37940910-B2E2D100-25B2-4746-AAB0-E1F6EA35BDD6Q38128298-89AB4A66-15D2-491B-B9B8-AE693FE8EAD3Q38582177-72B1D7BC-A217-4A69-9ADC-ED8E4A635DF5Q38889355-4E6718FD-657A-4C76-8689-EA5A40674B74Q39065285-DD667CF1-7EF4-45CC-A79D-8212EA49E0E7Q39109460-D81F645B-249C-446C-91F8-4278092907BCQ39734673-F73C61B6-2B33-492A-8B27-50E9CFCECF6DQ40977609-1DC68CEB-475A-477E-99D1-673FEB74833FQ41769679-8D04BA6C-274E-44B6-BBEA-85124880F240Q42623332-88107DDF-50EA-4035-A403-693216626DEDQ43865171-99FE40F3-C993-4A51-8B19-94E6419E4D71Q44652410-604B0B68-7BEA-422F-A901-08097314E7F5Q46075143-A95B03B8-A44A-41A8-867B-797E6133EA23Q46152521-B04DC68A-1CB7-4C77-8DDF-697CE92E28C2Q48667972-98E3ABD6-056D-4B15-852C-B0C6D7BC92BBQ49564644-924DCCD0-02F3-40D7-8E5F-F8A0C545AA02Q57825805-3BDBC259-05CA-4F86-AF0E-DBD3A01FFDF4Q59286551-2F658E21-EC7B-48C5-9FC8-0238957629A5
P2860
Lantibiotics: biosynthesis, mode of action and applications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lantibiotics: biosynthesis, mode of action and applications.
@ast
Lantibiotics: biosynthesis, mode of action and applications.
@en
type
label
Lantibiotics: biosynthesis, mode of action and applications.
@ast
Lantibiotics: biosynthesis, mode of action and applications.
@en
prefLabel
Lantibiotics: biosynthesis, mode of action and applications.
@ast
Lantibiotics: biosynthesis, mode of action and applications.
@en
P2093
P356
P1476
Lantibiotics: biosynthesis, mode of action and applications.
@en
P2093
Kuipers OP
van Kraaij C
P304
P356
10.1039/A804531C
P577
1999-10-01T00:00:00Z